These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11999157)

  • 1. Determination of the dosimetric characteristics of InterSource125 iodine brachytherapy source.
    Meigooni AS; Yoe-Sein MM; Al-Otoom AY; Sowards KT
    Appl Radiat Isot; 2002 Apr; 56(4):589-99. PubMed ID: 11999157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monte Carlo calculations and experimental measurements of the TG-43U1-recommended dosimetric parameters of 125I (Model IR-Seed2) brachytherapy source.
    Sheikholeslami S; Nedaie HA; Sadeghi M; Pourbeigy H; Shahzadi S; Zehtabian M; Hasani M; Meigooni AS
    J Appl Clin Med Phys; 2016 Jul; 17(4):430-441. PubMed ID: 27455485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental determination of the TG-43 dosimetric characteristics of EchoSeed model 6733 I25I brachytherapy source.
    Meigooni AS; Dini SA; Sowards K; Hayes JL; Al-Otoom A
    Med Phys; 2002 Jun; 29(6):939-42. PubMed ID: 12094988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetric characteristics of the InterSource103 palladium brachytherapy source.
    Meigooni AS; Sowards K; Soldano M
    Med Phys; 2000 May; 27(5):1093-100. PubMed ID: 10841414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosimetric characteristics of the Pharma Seed model BT-125-I source.
    Popescu CC; Wise J; Sowards K; Meigooni AS; Ibbott GS
    Med Phys; 2000 Sep; 27(9):2174-81. PubMed ID: 11011748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermoluminescent dosimetry of the selectseed 125I interstitial brachytherapy seed.
    Anagnostopoulos G; Baltas D; Karaiskos P; Sandilos P; Papagiannis P; Sakelliou L
    Med Phys; 2002 May; 29(5):709-16. PubMed ID: 12033566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental and theoretical determination of dosimetric characteristics of IsoAid ADVANTAGE 125I brachytherapy source.
    Meigooni AS; Hayes JL; Zhang H; Sowards K
    Med Phys; 2002 Sep; 29(9):2152-8. PubMed ID: 12349937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetric characteristics of a new 125I brachytherapy source.
    Gearheart DM; Drogin A; Sowards K; Meigooni AS; Ibbott GS
    Med Phys; 2000 Oct; 27(10):2278-85. PubMed ID: 11099194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Model 3500 125I brachytherapy source dosimetric characterization.
    Wallace RE
    Appl Radiat Isot; 2002 Apr; 56(4):581-7. PubMed ID: 11999156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monte Carlo and thermoluminescence dosimetry of the new IsoSeed model I25.S17 125I interstitial brachytherapy seed.
    Lymperopoulou G; Papagiannis P; Sakelliou L; Karaiskos P; Sandilos P; Przykutta A; Baltas D
    Med Phys; 2005 Nov; 32(11):3313-7. PubMed ID: 16370418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetric characteristics of the new RadioCoil 103Pd wire line source for use in permanent brachytherapy implants.
    Meigooni AS; Zhang H; Clark JR; Rachabatthula V; Koona RA
    Med Phys; 2004 Nov; 31(11):3095-105. PubMed ID: 15587663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric characteristics of the bests double-wall 103Pd brachytherapy source.
    Meigooni AS; Bharucha Z; Yoe-Sein M; Sowards K
    Med Phys; 2001 Dec; 28(12):2568-75. PubMed ID: 11797962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental and Monte Carlo determination of the TG-43 dosimetric parameters for the model 9011 THINSeed brachytherapy source.
    Kennedy RM; Davis SD; Micka JA; DeWerd LA
    Med Phys; 2010 Apr; 37(4):1681-8. PubMed ID: 20443489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric study of the new Intersource125 iodine seed.
    Reniers B; Vynckier S; Scalliet P
    Med Phys; 2001 Nov; 28(11):2285-8. PubMed ID: 11764034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calculated dosimetric parameters of the IoGold 125I source model 3631-A.
    Wierzbicki JG; Rivard MJ; Waid DS; Arterbery VE
    Med Phys; 1998 Nov; 25(11):2197-9. PubMed ID: 9829245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental determination of the Task Group-43 dosimetric parameters of the new I25.S17plus (125)I brachytherapy source.
    Moutsatsos A; Pantelis E; Papagiannis P; Baltas D
    Brachytherapy; 2014; 13(6):618-26. PubMed ID: 25108795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetry of the I-Plant Model 3500 iodine-125 brachytherapy source.
    Duggan DM; Johnson BL
    Med Phys; 2001 Apr; 28(4):661-70. PubMed ID: 11339764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of dosimetric characteristics of OptiSeed(TM) a plastic brachytherapy (103)Pd source.
    Wang Z; Hertel NE
    Appl Radiat Isot; 2005 Sep; 63(3):311-21. PubMed ID: 15964196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetry of the 198Au source used in interstitial brachytherapy.
    Dauffy LS; Braby LA; Berner BM
    Med Phys; 2005 Jun; 32(6):1579-88. PubMed ID: 16013717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monte Carlo and experimental dosimetry of an 1251 brachytherapy seed.
    Dolan J; Lia Z; Williamson JF
    Med Phys; 2006 Dec; 33(12):4675-84. PubMed ID: 17278820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.